GLENMEDE TRUST CO NA
BankPosition in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 314949
PHILADELPHIA, PA
Position in ARWR
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$239,802
-$255,612 QoQ
Shares Held
2,942
-81.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#368
of 497 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $148,775,467 across 46 Biotechnology names. ARWR ranks #40 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
538,822 | $61,080,861 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
488,546 | $12,360,212 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
206,405 | $11,810,493 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
141,317 | $11,060,881 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,621 | $10,987,396 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,722 | $6,319,398 | |
| 7 | VCEL |
Vericel Corp
|
139,921 | $6,225,084 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
7,637 | $2,413,979 |
All Filings in ARWR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $239,802 | 2,942 | Shares | Sole | 2026-08-10 | |
| 2023-12-31 | $495,414 | 16,190 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $454,237 | 16,905 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $357,634 | 10,029 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $254,736 | 10,029 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $635,291 | 15,663 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $511,019 | 15,462 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $352,346 | 10,007 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $460,221 | 10,007 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $664,193 | 10,018 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $624,737 | 10,007 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $831,347 | 10,038 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $663,564 | 10,007 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $768,681 | 10,018 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $430,600 | 10,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $433,109 | 10,028 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $307,752 | 10,697 | Shares | Defined | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||